Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Qing Yang

5PUBLICATIONS
2CO-AUTHORS
Molecular targetsOrganometallic chemistryPredictive and prognostic markersBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|May 14, 2026
H<sub>2</sub>S induces apoptosis of tumors with high IDO1 expression via NR4A1-BCL-2 and SOCS3 pathways.

|Jul 26, 2022
Copper-Promoted One-Pot Sandmeyer-Type Reaction for the Synthesis of <i>N</i>-Aryltriazoles.

Menghan Cui, Rong Wang, Qing Yang

|Feb 26, 2021
Forty-three key gene expressions involved in the effect of indoleamine 2,3-dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3-dioxygenase 1 inhibitor biomarker.

Weirui Li, Leilei Guo, Zikang Xing

|Oct 04, 2019
<i>N</i>-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase.

Dan Yang, Shengnan Zhang, Xin Fang

|Feb 20, 2019
H<sub>2</sub>S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma.

Dan Yang, Tianqi Li, Yinlong Li

Pageof 1

Frequent Collaborators

1 joint publications

Menghan Cui

1 joint publications

Zhen Ning Tony He

Frequent Collaborators

1 joint publications

Menghan Cui

1 joint publications

Zhen Ning Tony He